XOMA Corp (XOMA)
25.21
-0.23
(-0.90%)
USD |
NASDAQ |
May 03, 16:00
25.21
0.00 (0.00%)
After-Hours: 20:00
XOMA Revenue (Quarterly): 1.833M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.833M |
| September 30, 2023 | 0.83M |
| June 30, 2023 | 1.658M |
| March 31, 2023 | 0.437M |
| December 31, 2022 | 1.486M |
| September 30, 2022 | 0.451M |
| June 30, 2022 | 0.983M |
| March 31, 2022 | 3.107M |
| December 31, 2021 | 35.94M |
| September 30, 2021 | 0.94M |
| June 30, 2021 | 0.901M |
| March 31, 2021 | 0.375M |
| December 31, 2020 | 27.58M |
| September 30, 2020 | 0.557M |
| June 30, 2020 | 0.444M |
| March 31, 2020 | 0.804M |
| December 31, 2019 | 0.422M |
| September 30, 2019 | 8.855M |
| June 30, 2019 | 0.962M |
| March 31, 2019 | 8.131M |
| December 31, 2018 | 1.685M |
| September 30, 2018 | 0.896M |
| June 30, 2018 | 2.255M |
| March 31, 2018 | 0.463M |
| December 31, 2017 | 5.357M |
| Date | Value |
|---|---|
| September 30, 2017 | 36.18M |
| June 30, 2017 | 10.89M |
| March 31, 2017 | 0.26M |
| December 31, 2016 | 0.524M |
| September 30, 2016 | 0.635M |
| June 30, 2016 | 0.443M |
| March 31, 2016 | 3.962M |
| December 31, 2015 | 48.18M |
| September 30, 2015 | 2.074M |
| June 30, 2015 | 2.539M |
| March 31, 2015 | 2.651M |
| December 31, 2014 | 4.348M |
| September 30, 2014 | 5.136M |
| June 30, 2014 | 5.973M |
| March 31, 2014 | 3.41M |
| December 31, 2013 | 12.53M |
| September 30, 2013 | 6.312M |
| June 30, 2013 | 7.151M |
| March 31, 2013 | 9.453M |
| December 31, 2012 | 7.392M |
| September 30, 2012 | 7.251M |
| June 30, 2012 | 9.275M |
| March 31, 2012 | 9.865M |
| December 31, 2011 | 9.847M |
| September 30, 2011 | 16.23M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.375M
Minimum
Mar 2021
35.94M
Maximum
Dec 2021
4.662M
Average
0.94M
Median
Sep 2021
Revenue (Quarterly) Benchmarks
| Kinnate Biopharma Inc (DELISTED) | -- |
| Societal CDMO Inc (DELISTED) | 27.72M |
| Corcept Therapeutics Inc | 135.40M |
| Sarepta Therapeutics Inc | 413.46M |
| AnaptysBio Inc | 9.005M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.11M |
| Total Expenses (Quarterly) | 7.514M |
| EPS Diluted (Quarterly) | -1.87 |
| Enterprise Value | 266.42M |
| Profit Margin (Quarterly) | -1.10K% |
| Earnings Yield | -16.03% |
| Normalized Earnings Yield | -9.676 |